Sunpointe’s Medtronic MDT Stock Holding History

Sunpointe’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$300K	Buy	+3,831	New	+$309K	0.09%	202
2024 Q1	–	Sell	-2,555	Closed	-$212K	–	141
2023 Q4	$212K	Buy	+2,555	New	+$195K	0.27%	117

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Sunpointe's MDT Position: Q2 2026 in Review

Sunpointe opened a new position in Medtronic (MDT) in Q2 2026: 3,831 shares worth $300K. The stake represents 0.09% of the portfolio and ranks #202 among its holdings. This is a return to the name: Sunpointe previously reported a position in MDT as recently as Q4 2023.

Sunpointe first reported a position in MDT in Q4 2023 and has held it in 2 quarters since. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Sunpointe held 3,831 shares of Medtronic worth $300K as of Q2 2026.
Medtronic was a new Sunpointe position in Q2 2026.
Medtronic made up 0.09% of Sunpointe's portfolio in Q2 2026, its #202 holding.
Sunpointe first reported a position in Medtronic in Q4 2023 and has held it in 2 quarters since.
2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Sunpointe's 13F filing for Q2 2026, filed 24 Jul 2026.